1. Home
  2. IAM vs CII Comparison

IAM vs CII Comparison

Compare IAM & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IAM

Iambic Therapeutics Inc. Common Stock

N/A

Current Price

$16.48

Market Cap

896.3M

Sector

Health Care

ML Signal

N/A

Logo Blackrock Capital and Income Fund Inc.

CII

Blackrock Capital and Income Fund Inc.

SELL

Current Price

$23.45

Market Cap

1.1B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
IAM
CII
Founded
2019
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
896.3M
1.1B
IPO Year
2026
2004

Fundamental Metrics

Financial Performance
Metric
IAM
CII
Price
$16.48
$23.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
★ 64.6K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
★ 6.17%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$20.43
52 Week High
N/A
$26.17

Technical Indicators

Market Signals
Indicator
IAM
CII
Relative Strength Index (RSI) N/A 36.39
Support Level N/A $22.26
Resistance Level N/A $23.61
Average True Range (ATR) 0.00 0.34
MACD 0.00 -0.07
Stochastic Oscillator 0.00 15.38

Price Performance

Historical Comparison
IAM
CII

About CII Blackrock Capital and Income Fund Inc.

Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing in a portfolio of equity securities of U.S. and foreign issuers. It may invest directly in such securities or synthetically through the use of derivatives. It also seeks to achieve its investment objective by employing a writing (selling) call and put options.

Share on Social Networks: